ESTRO 2022 - Abstract Book

S605

Abstract book

ESTRO 2022

Figure 1

Figure 2

Conclusion Our work demonstrated current performance and identified areas for improvement within the radical lung RT pathway. Following implementation of the recommended changes, follow up work is planned to evaluate their impact. References 1 Lung Clinical Expert Group NHS England. National Optimal Lung Cancer Pathway; 2020. 2 Taylor R. et al. The Effects of Time to Treatment Initiation for Patients With Non–small-cell Lung Cancer in the United States; Clinical Lung Cancer; 2020.

PD-0671 Impact of FDG PET in small-cell lung cancer patients treated with curative intent chemoradiotherapy

A. Salem 1 , A. Abravan 2 , L. Sandhu 3 , C. Faivre-Finn 4 , M. Abutaleb 5 , C. Crockett 5 , G. Price 4

1 University of Manchester, Division of Cancer Sceinces, Manchester, United Kingdom; 2 University of Manchester, Division of Cancer Sciences , Manchester , United Kingdom; 3 University of Manchester, School of Medicine, Manchester, United Kingdom; 4 University of Manchester, Division of Cancer Sciences , Manchester, United Kingdom; 5 Christie NHS Foundation Trust, Clinical Oncology, Manchester, United Kingdom